TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Strängnäsvaccin AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
375
|
311
|
317 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
12
|
-20
|
-34 |
| EBITDA |
13
|
-7
|
-21 |
| Total assets |
99
|
111
|
151 |
| Current assets |
89
|
97
|
123 |
| Current liabilities |
9
|
9
|
13 |
| Equity capital |
90
|
102
|
138 |
| - share capital |
4
|
5
|
4 |
| Employees (average) |
3
|
0
|
0 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
90.9%
|
91.9%
|
91.4% |
| Turnover per employee | 125 | ||
| Profit as a percentage of turnover |
3.2%
|
-6.4%
|
-10.7% |
| Return on assets (ROA) |
12.1%
|
-18.0%
|
-22.5% |
| Current ratio |
988.9%
|
1077.8%
|
946.2% |
| Return on equity (ROE) |
13.3%
|
-19.6%
|
-24.6% |
| Change turnover |
74
|
-6
|
-24 |
| Change turnover % |
25%
|
-2%
|
-7% |
| Chg. No. of employees |
3
|
0
|
0 |
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.